| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Niagen Bioscience, Inc. (NAGE) has 8 insiders with recent SEC Form 4 filings, including 8 buys and 3 sells. NAGE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 20.0K | $83.8K | - | |
| Dir | 20.0K | $83.8K | - | |
| Dir | 20.0K | $83.8K | - | |
| Dir | 20.0K | $83.8K | - | |
| Dir | 20.0K | $83.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Pamir Ozan | Chief Financial Officer | Buy | 6,685 | $6.82 | $45,616.43 | +230.0% | -25.9% | - | |
| Mar 7, 2025 | Lopez Carlos Luis | SVP, General Counsel | Buy | 273 | $7.86 | $2,145.78 | +13.8% | +49.5% | -34.2% | |
| Dec 13, 2024 | Jaksch Frank L Jr | Director | Sale+OE | 37,161 | $6.19 | $229,955.98 | -13.2% | +26.1% | +6.5% | |
| Nov 22, 2024 | Pamir Ozan | Chief Financial Officer | Buy | 2,907 | $7.36 | $21,396.97 | New | -23.5% | -7.5% | |
| Aug 23, 2024 | Patrick Kristin | Director | Sale+OE | 23,000 | $3.57 | $82,110.00 | -100% | +117.4% | +184.3% | |
| Aug 20, 2024 | Li Ka Shing | 10% Owner | Sell | 11,408,715 | $0.00 | - | -100% | +117.7% | +188.3% | |
| Aug 20, 2024 | Chau Hoi Shuen Solina Holly61 | 10% Owner | Buy | 11,408,715 | $0.00 | - | +144.7% | +117.7% | +188.3% | |
| Dec 1, 2023 | Gerber Brianna | Chief Financial Officer | Buy | 5,000 | $1.41 | $7,050.00 | +22.3% | +18.4% | +447.5% | |
| Sep 6, 2023 | Champion River Ventures Ltd | Director, 10% Owner | Buy | 3,467,778 | $0.00 | - | +43.7% | -7.7% | +110.3% | |
| Jun 12, 2023 | Jaksch Frank L Jr | Director | Buy | 7,000 | $1.69 | $11,830.00 | +3.1% | -13.8% | +74.0% |